To study role of clinical variables and VKORC1 polymorphism in determination of stability of INR in neurological patients on acenocoumarol
Oral anticoagulation (OAC) is difficult to maintain in therapeutic range and their efficacy may be influenced by number of clinical and genetic variables. The objective of the study is to evaluate the role of VKORC1 polymorphism and correlate with stability of anticoagulation. It is a hospital based...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Science Planet Inc.
2017-10-01
|
| Series: | Canadian Journal of Biotechnology |
| Online Access: | https://www.canadianjbiotech.com/CAN_J_BIOTECH/Archives/v1/Special Issue/cjb.2017-a136.pdf |
| _version_ | 1811204256080855040 |
|---|---|
| author | Ashish Kant Dubey Surendra Kumar Jayantee Kalita Usha Kant Misra |
| author_facet | Ashish Kant Dubey Surendra Kumar Jayantee Kalita Usha Kant Misra |
| author_sort | Ashish Kant Dubey |
| collection | DOAJ |
| description | Oral anticoagulation (OAC) is difficult to maintain in therapeutic range and their efficacy may be influenced by number of clinical and genetic variables. The objective of the study is to evaluate the role of VKORC1 polymorphism and correlate with stability of anticoagulation. It is a hospital based study. Patients on OAC were included during 2013-2016. The patients received OAC for cardioembolic stroke, cortical venous sinus thrombosis (CVST) and prevention of deep vein thrombosis (DVT). Demographic, clinical and neurological findings were recorded. Stability of OAC was determined by percentage of international normalized ratio (INR) values in therapeutic range (PINR). PINR >65% were defined as stable and <65% was defined unstable. VKORC 1 polymorphism was studied by polymerase chain reaction and was related to daily dose of OAC and stability of INR. 157 patients with median age of 40 years were included. Ninety two patients received OAC for secondary stroke prevention, 62 for CVST and 3 for DVT. Out of 2976 INR reports, 1458 (49%) were in the therapeutic range, 997 (33.1%) were below and 521 (17.5%) above the therapeutic level. Stable INR was obtained in 75 (47.77%) patients only and was improved by drug modification in 3, and dietary adjustment in 12 patients. VKORC1 polymorphism revealed GG in 127 (80.9%), GA in 22 (14%) and AA genotype in 8 (5.1%) patients. Therapeutic range of INR was seen in 49%, below therapeutic range in 31.5% and above in 17.5%. VKORC1 polymorphism was related to mean daily dose of OAC but not to stability of INR. |
| first_indexed | 2024-04-12T03:08:50Z |
| format | Article |
| id | doaj.art-758068f46ed541ee88c76377f531d31b |
| institution | Directory Open Access Journal |
| issn | 2560-8304 |
| language | English |
| last_indexed | 2024-04-12T03:08:50Z |
| publishDate | 2017-10-01 |
| publisher | Science Planet Inc. |
| record_format | Article |
| series | Canadian Journal of Biotechnology |
| spelling | doaj.art-758068f46ed541ee88c76377f531d31b2022-12-22T03:50:25ZengScience Planet Inc.Canadian Journal of Biotechnology2560-83042017-10-011Special Issue15015010.24870/cjb.2017-a136To study role of clinical variables and VKORC1 polymorphism in determination of stability of INR in neurological patients on acenocoumarolAshish Kant Dubey0Surendra Kumar1Jayantee Kalita2Usha Kant Misra3Department of Neurology, Sanjay Gandhi Postgraduate Institute of Medical Science, Lucknow, INDIADepartment of Neurology, Sanjay Gandhi Postgraduate Institute of Medical Science, Lucknow, INDIADepartment of Neurology, Sanjay Gandhi Postgraduate Institute of Medical Science, Lucknow, INDIADepartment of Neurology, Sanjay Gandhi Postgraduate Institute of Medical Science, Lucknow, INDIAOral anticoagulation (OAC) is difficult to maintain in therapeutic range and their efficacy may be influenced by number of clinical and genetic variables. The objective of the study is to evaluate the role of VKORC1 polymorphism and correlate with stability of anticoagulation. It is a hospital based study. Patients on OAC were included during 2013-2016. The patients received OAC for cardioembolic stroke, cortical venous sinus thrombosis (CVST) and prevention of deep vein thrombosis (DVT). Demographic, clinical and neurological findings were recorded. Stability of OAC was determined by percentage of international normalized ratio (INR) values in therapeutic range (PINR). PINR >65% were defined as stable and <65% was defined unstable. VKORC 1 polymorphism was studied by polymerase chain reaction and was related to daily dose of OAC and stability of INR. 157 patients with median age of 40 years were included. Ninety two patients received OAC for secondary stroke prevention, 62 for CVST and 3 for DVT. Out of 2976 INR reports, 1458 (49%) were in the therapeutic range, 997 (33.1%) were below and 521 (17.5%) above the therapeutic level. Stable INR was obtained in 75 (47.77%) patients only and was improved by drug modification in 3, and dietary adjustment in 12 patients. VKORC1 polymorphism revealed GG in 127 (80.9%), GA in 22 (14%) and AA genotype in 8 (5.1%) patients. Therapeutic range of INR was seen in 49%, below therapeutic range in 31.5% and above in 17.5%. VKORC1 polymorphism was related to mean daily dose of OAC but not to stability of INR.https://www.canadianjbiotech.com/CAN_J_BIOTECH/Archives/v1/Special Issue/cjb.2017-a136.pdf |
| spellingShingle | Ashish Kant Dubey Surendra Kumar Jayantee Kalita Usha Kant Misra To study role of clinical variables and VKORC1 polymorphism in determination of stability of INR in neurological patients on acenocoumarol Canadian Journal of Biotechnology |
| title | To study role of clinical variables and VKORC1 polymorphism in determination of stability of INR in neurological patients on acenocoumarol |
| title_full | To study role of clinical variables and VKORC1 polymorphism in determination of stability of INR in neurological patients on acenocoumarol |
| title_fullStr | To study role of clinical variables and VKORC1 polymorphism in determination of stability of INR in neurological patients on acenocoumarol |
| title_full_unstemmed | To study role of clinical variables and VKORC1 polymorphism in determination of stability of INR in neurological patients on acenocoumarol |
| title_short | To study role of clinical variables and VKORC1 polymorphism in determination of stability of INR in neurological patients on acenocoumarol |
| title_sort | to study role of clinical variables and vkorc1 polymorphism in determination of stability of inr in neurological patients on acenocoumarol |
| url | https://www.canadianjbiotech.com/CAN_J_BIOTECH/Archives/v1/Special Issue/cjb.2017-a136.pdf |
| work_keys_str_mv | AT ashishkantdubey tostudyroleofclinicalvariablesandvkorc1polymorphismindeterminationofstabilityofinrinneurologicalpatientsonacenocoumarol AT surendrakumar tostudyroleofclinicalvariablesandvkorc1polymorphismindeterminationofstabilityofinrinneurologicalpatientsonacenocoumarol AT jayanteekalita tostudyroleofclinicalvariablesandvkorc1polymorphismindeterminationofstabilityofinrinneurologicalpatientsonacenocoumarol AT ushakantmisra tostudyroleofclinicalvariablesandvkorc1polymorphismindeterminationofstabilityofinrinneurologicalpatientsonacenocoumarol |